Digestive Disease Mortality Dynamics During New Coronavirus Infection Pandemic in Different Subjects of Russian Federation

Aim. An analysis of digestive disease mortality dynamics in different subjects of the Russian Federation in course of the new coronavirus infection pandemic.

Key points. In most subjects of the Russian Federation, the first half of 2021 enduring the COVID-19 pandemic has witnessed a higher overall mortality from digestive diseases and from peptic ulcer, liver and pancreatic illnesses compared to the same period in 2020. This situation may have roots in both the adverse impact of coronavirus infection on pre-existing digestive diseases and shortages in providing specialty medical aid to gastroenterological patients during the pandemic. Improved outpatient care and remote counselling, as well as successful educational measures, may reduce gastroenterological disease-associated mortality.

Conclusion. Most regions of Russia have registered a growing mortality from digestive diseases at the new coronavirus infection pandemic due to the SARS-CoV-2 adverse impact on illness progression, as well as imposed difficulties in providing specialty medical aid.

1. Ivashkin V.T., Sheptulin A.A., Zolnikova O.Yu., Okhlobystin A.V., Poluektova E.A., Trukhmanov A.S., et al. New Coronavirus Infection (COVID-19) and Digestive System. Rus J Gastroenterol Hepatol Coloproctol. 2020;30(3):7–13 (In Russ). DOI: 10.22416/1382-4376-2020-30-3-7

2. Patel P., Sebgupta N. PPIs and beyond: A framework for managing anticoagulation-related gastrointestinal bleeding in the era of COVID-19. Dig Dis Sci. 2020;65(8):2181–6. DOI: 10.1007/s10620-020-06408-x

3. Melazzini F., Lenti M.V., Mauro A., De Grazia F., Di Sabatino A. Peptic ulcer disease as a common cause of bleeding in patients with coronavirus disease 2019. Am J Gastroenterol. 2020;115(7):1139–40. DOI: 10.14309/ajg.0000000000000710

4. Mauro A., De Grazia F., Lenti M.V., Penagini R., Frego R., Ardizzone S., et al. Upper gastrointestinal bleeding in COVID-19 inpatients: Incidence and management in a multicenter experience from Northern Italy. Clin Res Hepatol Gastroenterol. 2021;45(3):101521. DOI: 10.1016/j.clinre.2020.07.025

5. Chen J., Hang Y. Characteristics, risk factors and outcomes of gastrointestinal hemorrhage in COVID-19 patients: A meta-analysis. Pak J Med Sci. 2021;37(5):1524– 31. DOI: 10.12669/pjms.37.5.4351

6. Liu S., Tang M.-M., Gong Z.-Ch., Sun S.-S. COVID-19 in gastroenterology and hepatology: Lessons learned and questions to be answered. World J Clin Cases. 2021;9(17):4199–209. DOI: 10.12998/wjcc.v9.i17.4199

7. Tellez L., Mateos R.M.M. COVID-19 and liver di sease: An update. Gastroenterol Hepatol. 2020;43(8):472– 80. DOI: 10.1016/j.gastrohep.2020.06.006

8. Iavarone M., D’Ambrosia R. , Soria A., Triolo M., Pugliese N., Del Poggio P., et al. High rates of 30-day mortality in patients with cirrhosis and COVID-19. J.Hepatol. 2020;73(5):1063–71. DOI: 10.1016/j.jhep.2020.06.001

9. Oyelade T., Algahtani J., Canciani G. Prognosis of COVID-19 in patients with liver and kidney diseases: An early systematic review and meta-analysis. Trop Med Infect Dis. 2020;5(2):80. DOI: 10.3390/tropicalmed5020080

10. Garrido I., Liberal R., Macedo G. Review article: COVID-19 and liver disease-what we know on 1st May 2020. Aliment. Pharmacol Ther. 2020;52(2):267–75. DOI: 10.1111/apt.15813

11. Su H.-Y., Hsu Y.-C. Patients with cirrhosis during the COVID-19 pandemic: Current evidence and future perspectives. World J Clin Cases. 2021;9(13):2951–68. DOI: 10.12998/wjcc.v9.i13.2951

12. Hunt R.H., East J.E., Lanas A., Malfertheiner P., Satsangi J., Scarpignato C., Webb G.W. COVID-19 and Gastrointestinal Disease: Implications for the Gastroenterologist. Dig Dis. 2021;39(2):119–39. DOI: 10.1159/000512152

13. Kim D., Bonham C.A., Konyn P., Cholankeril G., Ahmed A. Mortality trends in chronic liver disease and cirrhosis in the United States, before and during COVID-19 pandemic. Clin Gastroentero Hepatol. 2021;S1542- 3565(21)00723-0. DOI: 10.1016/j.cgh.2021.07.009

14. Сhin M.H. Uncomfortable truths — what Covid-19 has revealed about chronic-disease care in America. N Engl J Med. 2021;385:1633–6. DOI: 10.1056/NEJMp21112063

15. Scladny L., Koller T., Adamcova-Selcanova S., Vnencakova J., Jzncekova D, Durajova V., et al. Challenging management of severe chronic disorders in acute pandemic situation: Chronic liver disease under COVID-19 pandemic as the proof-of-principle model to orchestrate the measures in 3PM context. EPMA J. 2021;12(1):1–14. DOI: 10.1007/s13167-021-00231-8

16. Mikolasevic I., Bozic D., Pavic T., Ruzic A., Hauser G., Radic M. Liver disease in the era of COVID-19: Is the worst yet to come? World J Gastroenterol. 2021;27(36):6039– 52. DOI: 10.3748/wjg.v27.i36.6039

17. Hartl L., Semmler G., Hofer B.S., Schirwani N., Jachs M., Simbrunner B., et al. COVID-19-related downscaling of in-hospital liver care decreased patient satisfaction and increased liver-related mortality. Hepatol Commun. 2021;5(10):1660–75. DOI: 10.1002/hep4.1758

18. Donato G., Forti E. Mutignani M., Latwrra V.A., Arese D., Coppola F., et al. A multicenter survey on endoscopic retrograde cholangiopancreatography during the COVID-19 pandemic in northern and central Italy. Endosc Int Open. 2021;9(4):E629–34. DOI: 10.1055/a-1380-3419

19. Morais S., Antunes L., Rodrugues J., Fontes F., Bento M.J., Lunet L. The impact of the coronavirus disease 2019 pandemic on the diagnosis and treatment of cancer in Northern Portugal. Eur J Cancer Prev. 2021. DOI: 10.1097/CEJ.0000000000000686. Online ahead of print.

20. Buscarini E., Benedetti A., Monica F. Luigi P. Buttita F., Cameletti M., et al. Changes in digestive cancer diagnosis during the SARS-CoV-2 pandemic in Italy:A nationwide survey. 2021;53(6):682–8. DOI: 10.1016/j.dld.2021.02.021

21. Fadeeva M.V., Kudryavtseva A.V., Krasnov G.S., Skhirtladze M.R., Ivashkin V.T. Intestinal Microbiota in Patients with Chronic Heart Failure and Systolic Dysfunction. Rus J Gastroenterol Hepatol Coloproctol. 2020;30(2):35–44 (In Russ). DOI: 10.22416/1382-4376-2020-30-2-35-44

22. Ivashkin V., Fomin V., Moiseev S., Brovko M., Maslennikov R., Ulyanin A., et al. Efficacy of a Probiotic Consisting of Lacticaseibacillus rhamnosus PDV 1705, Bifidobacterium bifidum PDV 0903, Bifidobacterium longum subsp. infantis PDV 1911, and Bifidobacterium longum subsp. longum PDV 2301 in the Treatment of Hospitalized Patients with COVID-19: a Randomized Controlled Trial. Probiotics Antimicrob Proteins. 2021:1–9. DOI: 10.1007/s12602-021-09858-5

23. Ulyanin A.I. “Gastrointestinal Microbiota in Children and Adults. Viruses and Bacteria”, an online conference of Scientific Society for the Study of Human Microbiome 14.11.2020. Rus J Gastroenterol Hepatol Coloproctol. 2020;30(6):86–8 (In Russ.). DOI: 10.22416/1382-4376-2020-30-6-86-88